Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally
Clinical trial NCT00436046 · COMPLETED
Trial details
- NCT number
- NCT00436046
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2007-04-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.